72 related articles for article (PubMed ID: 10758014)
1. When and where to start: guidelines for the initiation of antiretroviral therapy.
Volberding P
AIDS Read; 2000 Mar; 10(3):150-5; discussion 171-4. PubMed ID: 10758014
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
3. Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières.
Pujades-Rodríguez M; O'Brien D; Humblet P; Calmy A
AIDS; 2008 Jul; 22(11):1305-12. PubMed ID: 18580610
[TBL] [Abstract][Full Text] [Related]
4. API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.
Gupta SB; Pujari SN; Joshi SR; Patel AK;
J Assoc Physicians India; 2006 Jan; 54():57-74. PubMed ID: 16649742
[TBL] [Abstract][Full Text] [Related]
5. When to switch and what to switch to: strategic use of antiretroviral therapy.
Gulick R
AIDS Read; 2000 Mar; 10(3):156-61; discussion 171-4. PubMed ID: 10758015
[TBL] [Abstract][Full Text] [Related]
6. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
7. NNRTI plus PI combinations in the perspective of nucleoside-sparing or nucleoside-failing antiretroviral regimens.
Joly V; Descamps D; Yeni P
AIDS Rev; 2002; 4(3):128-39. PubMed ID: 12416447
[TBL] [Abstract][Full Text] [Related]
8. Simply stated...on your mark, get set, go.
Res Initiat Treat Action; 1998 Jul; 4(4):15. PubMed ID: 11365644
[TBL] [Abstract][Full Text] [Related]
9. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
10. When to start therapy--and what to start with.
Gallant JE
Posit Aware; 1997; 8(1):22-3. PubMed ID: 11364093
[TBL] [Abstract][Full Text] [Related]
11. When to start?
Bartlett J; Cohn D
AIDS Clin Care; 1999 May; 11(5):38, 43. PubMed ID: 11367103
[TBL] [Abstract][Full Text] [Related]
12. Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia.
Mocroft A; Phillips AN; Ledergerber B; Katlama C; Chiesi A; Goebel FD; Knysz B; Antunes F; Reiss P; Lundgren JD
AIDS; 2006 May; 20(8):1141-50. PubMed ID: 16691065
[TBL] [Abstract][Full Text] [Related]
13. Long-term strategies: should some patients wait to start protease inhibitors? Interview with Keith Henry, M.D. Interview by John S. James.
Henry K
AIDS Treat News; 1997 Oct; (No 281):1, 3-6. PubMed ID: 11364791
[TBL] [Abstract][Full Text] [Related]
14. [Revised guideline "Antiretroviral Treatment"].
Werkgroep antiretrovirale behandeling van de Nederlandse Vereniging van Aids Behandelaren
Ned Tijdschr Geneeskd; 2005 Oct; 149(43):2399-405. PubMed ID: 16277129
[TBL] [Abstract][Full Text] [Related]
15. Adherence to combination antiretroviral therapy: synthesis of the literature and clinical implications.
Miller LG; Hays RD
AIDS Read; 2000 Mar; 10(3):177-85. PubMed ID: 10758022
[TBL] [Abstract][Full Text] [Related]
16. Boosted protease inhibitor-based or nonnucleoside reverse transcriptase-based HAART: is there a best choice for antiretroviral-naive HIV-1 infected patients?
Cuzin L; Allavena C; Morlat P; Dellamonica P
AIDS Rev; 2008; 10(4):205-11. PubMed ID: 19092976
[TBL] [Abstract][Full Text] [Related]
17. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral management of treatment-naive patients.
Gulick RM
Infect Dis Clin North Am; 2007 Mar; 21(1):71-84, viii. PubMed ID: 17502230
[TBL] [Abstract][Full Text] [Related]
19. Response to antiretroviral therapy among patients exposed to three classes of antiretrovirals: results from the EuroSIDA study.
Mocroft A; Phillips AN; Friis-Møller N; Colebunders R; Johnson AM; Hirschel B; Saint-Marc T; Staub T; Clotet B; Lundgren JD;
Antivir Ther; 2002 Mar; 7(1):21-30. PubMed ID: 12008784
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial investigating the efficacy and safety of switching from a protease inhibitor to nevirapine in patients with undetectable viral load.
Arranz Caso JA; López JC; Santos I; Estrada V; Castilla V; Sanz J; Sanz J; Molina JP; Fernández Guerrero M; Górgolas M
HIV Med; 2005 Sep; 6(5):353-9. PubMed ID: 16156884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
